Stay informed with the latest litigation news. Explore now

(Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved Stability - EP2477611B1

EP2477611

SANOFI
Application Number
EP10752585A
Filing Date
Sep 14, 2010
Status
Revoked
Feb 14, 2023
Grant Date
Apr 5, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2477611B1 was granted to Sanofi on Apr 5, 2017 following the initial filing on Sep 14, 2010 under the application number EP10752585A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PENTAFARMA SOCIEDADE TECNICO MEDICINALJan 4, 2018ADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBDec 29, 2017ADMISSIBLE
COOKEDec 19, 2017ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents